Instead, document your symptoms and contact your GP or diabetes team to discuss any significant menstrual changes and exclude other causes
This is especially important if you have diabetes, take glucose-lowering medicines, have a history of pancreatitis or gallbladder disease, have severe gastrointestinal symptoms, or have kidney problems
Tirzepatide targets both GLP-1 and GIP receptors, which can lead to even greater weight loss and blood sugar control
adults are either currently taking or considering a GLP-1 drug for weight loss purposes, according to recent data from Civic Science
IL-23-induced synovial inflammation is primarily linked to the activation of JAK-STAT, tyrosine kinase 2, NF-B, and retinoic acid receptor-related orphan receptors (RORs) (80)
doi:10.3390/antiox12040834